Home Test Kit Detects Bladder Cancer with 88.8% Accuracy
Researchers developed a urine-based diagnostic kit for bladder cancer, offering a solution for early detection and monitoring at home.
Tag: cancer liquid biopsies
All
Latest
All
Latest
Florida Selects DiaCarta’s cfDNA Test to Detect Early Response of Cancer Treatment
The Florida Health Department will use DiaCarta's RadTox test for early detection of cancer treatment response and resistance.
All
Latest
Final Results of GRAIL’s Multi-Cancer Early Detection Blood Test Revealed
GRAIL’s multi-cancer early detection blood test supported diagnostic resolution for the majority of participants in less than three months.
PDACatch an FDA Breakthrough Device for Pancreatic Cancer Detection
Singlera Genomics’ PDACatch assay is a novel DNA methylation-based liquid biopsy assay for the detection of pancreatic adenocarcinoma in individuals at high risk for the disease.
Read More
Blood-Based Colon Cancer Test Provides Early Detection
Beacon Biomedical released a colon cancer screening test designed to improve access and affordability to CRC screening as a blood draw.
Read More
Blood Biomarkers Predict Neuroendocrine Tumor Response to Radiopharmaceutical Therapy
A simple blood draw can help determine if peptide receptor radionuclide therapy is effective in a patient with neuroendocrine cancer.
Read More
Guardant Health Submits FDA Premarket Approval Application for Colon Cancer Blood Test
Guardant Health submitted the final module of its premarket approval application for a colon cancer screening blood test to the FDA.
Read More
Exai Bio Expands RNA-based Breast Cancer Liquid Biopsy Platform through Collaboration
Exai Bio is collaborating with Quantum Leap Healthcare Collaborative to broaden the use of its novel, RNA-based liquid biopsy platform.
Read More
Rapid Novor’s Multiple Myeloma Monitoring Blood Test Gets CLIA Certification
Rapid Novor obtained the CLIA certification for its EasyM assay for Multiple Myeloma as a laboratory developed test.
Read More
Children’s Hospital LA Develops Liquid Biopsy for Pediatric Tumors
Investigators at Children’s Hospital Los Angeles investigators have developed a liquid biopsy for pediatric solid tumors.
Read More
Biomarker for Brain Cancer Blood Test Identified
Researchers have identified a biomarker that can be used in blood tests to diagnose glioblastoma (GBM), a common type of brain cancer.
Read More
LynxDx Launches Non-invasive Prostate Cancer Screening Solution
LynxDx is introducing a non-invasive, data-driven, urine prostate cancer screening test to guide clinical decisions for patients.
Read More
New Prostate Cancer Blood Test with 94% Accuracy
Researchers at the University of East Anglia helped develop a blood test to detect prostate cancer with greater accuracy than current methods.
Read More
Scientists Develop Device to Detect Brain Tumors Using Urine
Researchers developed a new device to identify a key membrane protein in urine that indicates whether the patient has a brain tumor.
Read More
A Blood Test for Better Prostate Cancer Diagnostics
Investigators found that the test was able to distinguish cancer localized to the prostate from cancer that spread to other parts of the body.
Read More
Datar Blood Test for Brain Tumor Diagnosis Gets Breakthrough Device Designation
The FDA granted Datar Cancer Genetics Breakthrough Device Designation for its TriNetra-Glio test, a liquid biopsy to diagnose brain tumors.
Read More
Burning Rock’s Multi-Cancer Detection Blood Test Gets FDA Breakthrough Device Designation
Burning Rock announced that its OverC Multi-Cancer Detection Blood Test has been granted Breakthrough Device Designation by the FDA.
Read More
New Prediction Algorithm Could Help Target Risk of Developing Prostate Cancer
Cambridge scientists have created a comprehensive tool for predicting an individual’s risk of developing prostate cancer.
Read More